Home › Funds › Birchview Capital, LP › FHTX
Birchview Capital, LP position in FHTX
FOGHORN THERAPEUTICS INC · Health Care
Birchview Capital, LP reported holding 282,307 shares of FHTX (FOGHORN THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$1.0M, representing 0.60% of its reported portfolio and ranking #39 among its reported holdings. Birchview Capital, LP has disclosed FHTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Birchview Capital, LP's FHTX position evolved
Birchview Capital, LP first disclosed a stake in FHTX in Q3 2023 at 264,843 shares (US$1.3M). The position peaked in Q3 2024 at 320,930 shares, worth US$3.0M. Across 13 filings, Birchview Capital, LP increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 9 time(s). The most recent filing (Q3 2026) shows 282,307 shares valued at US$1.0M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 264.84K | $1.32M | New |
| Q4 2023 | 320.93K | $2.07M | Add |
| Q1 2024 | 320.93K | $2.15M | Hold |
| Q2 2024 | 320.93K | $1.85M | Hold |
| Q3 2024 | 320.93K | $2.99M | Hold |
| Q4 2024 | 310.93K | $1.47M | Reduce |
| Q1 2025 | 310.93K | $1.13M | Hold |
| Q2 2025 | 310.93K | $1.46M | Hold |
| Q3 2025 | 281.73K | $1.38M | Reduce |
| Q4 2025 | 281.73K | $1.52M | Hold |
| Q1 2026 | 281.73K | $1.35M | Hold |
| Q2 2026 | 281.94K | $1.38M | Hold |
| Q3 2026 | 282.31K | $1.01M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About FHTX and 13F data
FHTX (FOGHORN THERAPEUTICS INC) is a Health Care company. 33 other funds we track also report a position in FHTX — the largest reported positions include Flagship Pioneering, LLC (US$61.8M), BVF INC/IL (US$28.5M), Euclidean Capital LLC (US$7.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding FHTX
- Flagship Pioneering, LLC 12.67M sh · $61.85M · Q2 2026
- BVF INC/IL 5.84M sh · $28.51M · Q2 2026
- Euclidean Capital LLC 1.57M sh · $7.68M · Q2 2026
- B Group, Inc. 200.00K sh · $976.00K · Q2 2026
More on Birchview Capital, LP
FAQ
How long has Birchview Capital, LP held FHTX?
Birchview Capital, LP has disclosed FHTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Birchview Capital, LP's current position in FHTX?
As of Q3 2026, Birchview Capital, LP holds 282.31K shares of FHTX (FOGHORN THERAPEUTICS INC), valued at $1.01M, representing 0.60% of its reported portfolio and ranking #39.
Has Birchview Capital, LP been buying or selling FHTX?
In the latest 13F filing (Q3 2026), Birchview Capital, LP held unchanged its position in FHTX. The position peaked in Q3 2024 at 320.93K shares.
Which other funds hold FHTX?
Other major institutional holders of FHTX include Flagship Pioneering, LLC, BVF INC/IL, Euclidean Capital LLC, among 33 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.